Immunomodulation of human T cell responses with receptor selective enkephalins.
The delta-opioid receptor selective [2-D-penicillamine-5-D-penicillamine] enkephalin (DPDPE) and the mu receptor selective Tyr-D-Orn-Phe-Asp-NH2 (TOPA) were found respectively, to have marked immunostimulant and immunosuppressant activities in both normal subjects and patients suffering from leprosy and tuberculosis. Antigen specific lymphoproliferation and numbers of rosette forming T cells were significantly (P < 0.05) enhanced on in vitro treatment with Met-enkephalin. This was further increased (P < 0.001) in the presence of the delta selective DPDPE. In contrast, treatment with mu selective TOPA inhibited lymphoproliferation substantially (P < 0.01) and rosette formation to a lesser extent.
Mazumder
S
S
Department of Biotechnology, All India Institute of Medical Sciences, New Delhi.
Nath
I
I
Dhar
M M
MM
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000595:Amino Acid Sequence; D020881:Enkephalin, D-Penicillamine (2,5)-; D004744:Enkephalin, Methionine / Q000494:pharmacology; D004745:Enkephalins / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D007918:Leprosy / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects; D008969:Molecular Sequence Data; D018847:Opioid Peptides; D010456:Peptides, Cyclic / Q000494:pharmacology; D017465:Receptors, Opioid, delta / Q000187:drug effects / Q000276:immunology; D017450:Receptors, Opioid, mu / Q000187:drug effects / Q000276:immunology; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000187:drug effects* / Q000276:immunology / Q000378:metabolism; D014397:Tuberculosis, Pulmonary / Q000276:immunology
D000276:Adjuvants, Immunologic; D004745:Enkephalins; D007166:Immunosuppressive Agents; D018847:Opioid Peptides; D010456:Peptides, Cyclic; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D004744:Enkephalin, Methionine; D020881:Enkephalin, D-Penicillamine (2,5)-; C053975:cyclo(tyrosyl-ornithyl-phenylalanyl-aspartamide)